Inventor · disambiguated record
Ales Medek
Also filed as: MEDEK ALES
22 granted patents·19 pending applications·448 citations·filing 2010–2024
96Inventor score
Top patents by PatentIndex Score
41 records- 0197US8741922B2Solid forms of N-(4-(7-azabicyclo[2.2,1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamideVERTEX PHARMA·Filed 2013·Granted Jun 3, 2014·68 cites·9 claims
- 0296US11873300B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Jan 16, 2024·6 cites·25 claims
- 0396US8785476B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2012·Granted Jul 22, 2014·72 cites·9 claims
- 0496US8389727B2Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-CarboxamideZHANG BEILI·Filed 2010·Granted Mar 5, 2013·85 cites·53 claims
- 0594US10980746B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2018·Granted Apr 20, 2021·13 cites·25 claims
- 0694US8471029B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideAREKAR SNEHA G·Filed 2011·Granted Jun 25, 2013·85 cites·15 claims
- 0793US10206877B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2015·Granted Feb 19, 2019·29 cites·27 claims
- 0893US9701639B2Co-crystals of modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Jul 11, 2017·41 cites·21 claims
- 0992US11951212B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2021·Granted Apr 9, 2024·3 cites·37 claims
- 1091US12060346B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Aug 13, 2024·1 cites·53 claims
- 1191US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 1291US11618746B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2019·Granted Apr 4, 2023·6 cites·28 claims
- 1391US9856284B2Solid forms of a thiophosphoramidate nucleotide prodrugALIOS BIOPHARMA INC·Filed 2016·Granted Jan 2, 2018·5 cites·20 claims
- 1489US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 1589US10815239B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2018·Granted Oct 27, 2020·3 cites·25 claims
- 1686US9771361B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Sep 26, 2017·8 cites·48 claims
- 1786US9394330B2Solid forms of a thiophosphoramidate nucleotide prodrugALIOS BIOPHARMA INC·Filed 2014·Granted Jul 19, 2016·7 cites·43 claims
- 1885US12319693B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 1983US8916538B2Solid forms of a thiophosphoramidate nucleotide prodrugVERTEX PHARMA·Filed 2013·Granted Dec 23, 2014·5 cites·28 claims
- 2079US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 2179US10160760B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted Dec 25, 2018·3 cites·63 claims
- 2278US2025042878A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2368US11485739B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2020·Granted Nov 1, 2022·0 cites·18 claims
- 2468US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2561US2025340568A1Solid forms of a macrocyclic compounds as cftr modulators and their preparationVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2661US2025320226A1Methods of preparing and crystalline forms of (6a,12a)-17-amino-12-methyl-6,15-bis(trifluoromethyl)-13,19-dioxa-3,4,18-triazatricyclo[12.3.1.12,5]nonadeca-1(18),2,4,14,16-pentaen-6-olVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2760US2014329855A1Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2858US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2958US2019038615A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 3057US2024158404A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3157US2013338188A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3257US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3357US2023203000A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3456US2018153874A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 3556US2013018071A1Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3652US2024002386A1Solid forms of 4-(5-(4-fluorophenyl)-6-(tetrahydro-2h-pyran-4-yl)-1,5-dihydropyrrolo[2,3-f]indazol-7-yl)benzoic acidVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3752US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3851US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 3949US2016067239A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4047US2023119114A1Solid forms of apol1 inhibitors and methods of using sameVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 4145US2021246121A1Solid forms of apol1 inhibitor and methods of using sameVERTEX PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ales Medek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →